Deep Track Capital, LP Pliant Therapeutics, Inc. Transaction History
Deep Track Capital, LP
- $2.71 Billion
- Q3 2024
A detailed history of Deep Track Capital, LP transactions in Pliant Therapeutics, Inc. stock. As of the latest transaction made, Deep Track Capital, LP holds 5,972,257 shares of PLRX stock, worth $83.6 Million. This represents 2.47% of its overall portfolio holdings.
Number of Shares
5,972,257
Previous 5,972,257
-0.0%
Holding current value
$83.6 Million
Previous $64.2 Million
4.28%
% of portfolio
2.47%
Previous 2.11%
Shares
7 transactions
Others Institutions Holding PLRX
# of Institutions
168Shares Held
63.2MCall Options Held
245KPut Options Held
373K-
Black Rock Inc. New York, NY4.97MShares$69.6 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD4.83MShares$67.7 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.53MShares$49.4 Million0.0% of portfolio
-
Redmile Group, LLC San Francisco, CA3.2MShares$44.8 Million2.34% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY3.1MShares$43.5 Million1.25% of portfolio
About PLIANT THERAPEUTICS, INC.
- Ticker PLRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 48,682,000
- Market Cap $682M
- Description
- Pliant Therapeutics, Inc., a clinical stage biopharmaceutical company, discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related diseases in the United States. Its lead product candidate is PLN-74809, an oral small-molecule dual selective inhibitor of avß6 and avß1 integrins, which is in three Phase 2a tri...